Are you Dr. Gheuens?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
E/Cls-1017
Boston, MA 02215Phone+1 617-735-4468Fax+1 617-735-4527
Summary
- Dr. Sarah Gheuens, MD is a neurologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Instructor at Beth Israel Deaconess Medical Center.
Education & Training
Vrije Universiteit BrusselsClass of 2004
Certifications & Licensure
MA State Medical License 2011 - 2025
Publications & Presentations
PubMed
- 145 citationsSafety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.Jacob Elkins, Roland Veltkamp, Joan Montaner, S. Claiborne Johnston, Aneesh B. Singhal
The Lancet. Neurology. 2017-03-01 - 1305 citationsNusinersen versus Sham Control in Infantile-Onset Spinal Muscular AtrophyRichard S. Finkel, Eugenio Mercuri, Basil T. Darras, Anne M. Connolly, Nancy L. Kuntz
The New England Journal of Medicine. 2017-11-01 - 360 citationsNusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study.Darryl C. De Vivo, Enrico Bertini, Kathryn J. Swoboda, Wuh-Liang Hwu, Thomas O. Crawford
Neuromuscular Disorders. 2019-09-12
Press Mentions
Centogene and Agios Expand Rare Blood Disease PartnershipNovember 5th, 2021- Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin ResponseJune 27th, 2023
- Viridian Appoints Sarah Gheuens, M.D., Ph.D., to Its Board of DirectorsSeptember 26th, 2023
- Join now to see all
